CTAGE7P

Across TCGA pan-cancer cohorts, CTAGE7P RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of CTAGE7P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CTAGE7P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CTAGE7P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC, BLCA, and COAD are the cancer types where CTAGE7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTAGE7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.168	<.001	11	view →
BLCA	All	All	+0.238	<.001	9	view →
COAD	Male	II,III,IV	+0.389	<.001	8	view →
LIHC	All	II,III,IV	+0.134	<.001	7	view →
HNSC	All	II,III,IV	+0.090	.005	6	view →
STAD	All	II,III,IV	+0.318	.005	5	view →
LUAD	All	All	+0.296	<.001	5	view →
LUSC	All	All	+0.215	<.001	4	view →
BRCA	All	II,III,IV	+0.161	.015	4	view →
THCA	Male	III,IV	−0.208	.022	3	view →
KICH	All	II,III,IV	+0.202	.012	3	view →
CHOL	All	All	+0.735	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

CTAGE7P–KIRC

Open the KIRC breakdown →